Toluene: Where You're Exposed and What the Research Shows

Self-sampling researchers in Baltimore measured this exposure in 2021. Across 32 consumer refuelling events self-sampled in Baltimore, MD; geometric mean breathing-zone toluene 9.5 ppb during a single fill — Patton et al. 2021, the geometric mean breathing-zone toluene during a single fill ran at 9.5 parts per billion Patton et al. 2021 — roughly a thimble of solvent dispersed across an Olympic swimming pool of air, inhaled in five minutes. Benzene, the carcinogen that travels with toluene in every drop of petrol, sat at 3.2 ppb in the same air. Both numbers are well below the threshold for acute harm in a healthy adult. Both numbers are not zero.

Toluene is the most-used aromatic solvent on earth — paint, glue, ink, gasoline, nail polish, contact cement, model dope, dry-cleaning fluids, shoe polish. It is part of the broader story of solvents that interact with the developing nervous system and the developing fetus, and it is one of the few major industrial chemicals where the regulatory picture has clearly stalled. The OSHA limit was set in 1971 and has not been touched since. This article is about where you encounter it, what it does, and why the U.S. federal occupational standard is fifty-five years out of date.

Toluene (C₇H₈, CAS 108-88-3, also called methylbenzene) is a clear, sweet-smelling aromatic hydrocarbon used as the solvent base for paints, inks, adhesives, lacquers, and nail polish. It evaporates fast at room temperature, dissolves oily and resinous compounds at high concentrations, and is one of the four BTEX compounds — BTEXBenzene, toluene, ethylbenzene, xylene — the four most abundant aromatic volatile organic compounds in petrol vapor, indoor air, and ambient urban air. Industrial production is in the millions of tonnes per year, the bulk of it consumed inside refineries to make benzene and other downstream chemistry.

It is a volatile organic compoundAn organic chemical with appreciable vapor pressure at room temperature, capable of evaporating into the air from a liquid surface and entering the lungs as a gas, which means it gets into you primarily through the lungs — when paint dries, when polish remover sits on a cuticle, when the petrol cap comes off. Skin absorption is real but slower; ingestion is rare outside accidental poisoning. Once inside, toluene crosses the blood-brain barrier within minutes and is cleared mainly through the liver, which converts it to hippuric acid that the kidneys excrete. The biological half-life is short — hours, not days. The harm comes from chronic repeated exposure, not a single bad afternoon.

Crucially: toluene is not a carcinogen. IARCInternational Agency for Research on Cancer evaluated it in 1999 (Monograph Volume 71) and concluded toluene is 'not classifiable as to its carcinogenicity to humans (Group 3)' — finding inadequate evidence in humans and evidence suggesting lack of carcinogenicity in experimental animals (IARC 1999, Vol 71). No re-evaluation has been published since. The Group 1 carcinogen in the BTEX cluster is benzene. Toluene's harms are neurobehavioral and developmental — and they are real, just located somewhere else.

Toluene reaches the consumer through three routes: solvent-based products (paint, polish, glue, adhesive), petrol vapor (refuelling, traffic-dense areas, garage attached to a house), and indoor air loaded by recent solvent use. Cigarette smoke is the dominant route for active smokers — biomonitoring of U.S. blood toluene tracks linearly with cigarettes per day.

The two routes that matter most for non-occupational exposure are nail polish and petrol vapor. EU Cosmetics Regulation 1223/2009 (Annex III, entry 185) caps toluene in nail products at 25% by weight, restricted to professional and adult use. EU Restricted to 25% in nail polish 2009 The U.S. has no equivalent federal cosmetics restriction. US No federal cap on cosmetic toluene 2026 Major U.S. brands removed it voluntarily from mass-market polish around 2006-2007 under campaign pressure from the Campaign for Safe Cosmetics — the so-called Toxic TrioToluene, dibutyl phthalate, and formaldehyde — the three ingredients targeted in the 2006-2007 campaign that pushed OPI, Orly, Sally Hansen and others to reformulate — but salon-grade and budget polish lines still use it as the solvent base. Read the back of the bottle.

Petrol is the second route. Commercial gasoline contains toluene in the single-digit volume percentage range as a knock-resistance and cold-start additive. The exposure happens during refuelling, in traffic, near filling-station forecourts, and inside attached garages where a parked car off-gasses overnight. For a non-smoking adult who fills a car twice a week, the cumulative dose is small. For a forecourt attendant or a home-mechanic who works in a closed garage, the cumulative dose adds up. The chemistry doesn't care which one of those people you are.

Chronic occupational toluene exposure produces measurable, dose-dependent deficits in color vision — specifically acquired color vision deficiencyA loss of normal colour discrimination produced by exposure to a neurotoxin or by retinal/optic-nerve disease, distinct from the inherited red-green colour blindness most people associate with the term; detected with the Lanthony D-15 desaturated panel — along with reaction time and working memory effects at concentrations below the OSHA workplace ceiling. The strongest evidence comes from three complementary studies: a 1990 Singaporean electronics-factory cohort; a 2000 Italian rubber-industry cohort tested with the Lanthony D-15A clinical color-vision test using fifteen colored caps the patient arranges in order of hue; deviations score the type and severity of acquired color deficits color-vision panel; and a 2001 French printing-industry cohort with 125 male workers tested across three exposure tiers.

The OSHAOccupational Safety and Health Administration permissible exposure limit for toluene is 200 ppm 8-hour time-weighted average; OSHA 29 CFR 1910.1000 Table Z-2; this PEL was set in 1971 and has not been updated since as an 8-hour time-weighted average — set in 1971 under the original Z-list. The ACGIHAmerican Conference of Governmental Industrial Hygienists threshold limit value is 20 ppm 8-hour TWA; ACGIH 2024-2025 TLVs and BEIs booklet — ten times lower than the OSHA legal limit, based on accumulated neurobehavioral evidence, ten times lower. Same chemical, same biology, two regulators, a factor of ten between them, and the legal one is the older one.

Here's how the neurobehavioral evidence accumulated. In 1990, a Singapore electronics plant let researchers measure the air. The toluene concentration came in at 88 ppm 8-hour TWA — well below the then-prevailing 100 ppm occupational limit. 30 female workers electronics-factory workers exposed to toluene at 88 ppm time-weighted average vs 30 matched controls at 13 ppm — Foo, Jeyaratnam & Koh 1990, Br J Ind Med 47(7) from the high-exposure side were matched to 30 controls from a low-exposure section (13 ppm TWA) and run through a six-test battery: digit-symbol substitution, simple reaction time, finger tapping, trail-making, manual dexterity, mood profile. The exposed workers performed worse on every test that measured speed, attention, and short-term memory Foo et al. 1990. The level they were working under was less than half the regulatory ceiling and already enough to show up on a standard cognitive screen.

Eleven years later, Campagna and colleagues ran a similar protocol on French rotogravure printers — 72 toluene-exposed at airborne concentrations generally below the ACGIH TLV of 50 ppm in force at the time, 34 background-exposed comparison workers, and 19 unexposed referents. The Color Confusion Index from the Lanthony D-15 panel rose with current air toluene at an odds ratio of 1.27 95% CI 1.02-1.58, per unit current airborne exposure; Campagna et al. 2001 — color confusion index per unit toluene per unit current air concentration (95% CI 1.02-1.58), and at 1.21 (1.04-1.39) per unit cumulative lifetime exposure Campagna et al. 2001. Cavalleri's earlier 2000 Italian cohort had found the same gradient in rubber-industry workers below the OEL Cavalleri et al. 2000. The pattern repeats across industries: subclinical color-vision loss, dose-related to cumulative exposure, detectable below the regulatory limit.

When the ATSDRAgency for Toxic Substances and Disease Registry updated its toxicological profile in 2017, it set the chronic inhalation Minimal Risk Level at 1 ppm 3.8 mg/m³ — ATSDR Toxicological Profile for Toluene tp56, June 2017; chronic inhalation MRL anchored on Foo 1990's 88 ppm exposure cohort with safety factors applied (3.8 mg/m³) — anchored explicitly on Foo's 1990 electronics-worker cohort, time-adjusted to 10.7 ppm and divided by an uncertainty factor of 10 (ATSDR Toxicological Profile tp56, 2017). The acute MRL is 2 ppm. The EPAUnited States Environmental Protection Agency reference concentration via IRISIntegrated Risk Information System — the EPA's database of human-health hazard assessments and reference values for environmental chemicals sits higher at 5 mg/m³ (about 1.3 ppm) and the oral reference dose at 0.08 mg/kg/day (EPA IRIS, last updated 23 September 2005). Three federal frameworks. All three set the long-term exposure benchmark below 5 ppm. The OSHA workplace limit is 200.

The reproductive evidence is the part of the toluene story that won the chemical its place on California's Proposition 65 list as a developmental toxicant in 1991. US-CA Listed as developmental toxicant under Proposition 65 1991 The Maximum Allowable Dose Levels are 13,000 µg/day inhalation and 7,000 µg/day oral — orders of magnitude above any consumer-product use scenario, but the listing itself reframes the chemical.

The clinical evidence is unsettling. In 1985, three children of mothers who had inhaled large quantities of pure toluene throughout pregnancy presented to clinicians at the University of Louisville with a striking pattern — microcephaly, central nervous system dysfunction, minor craniofacial and limb anomalies, variable growth deficiency. Hersh and colleagues described the cases as 'toluene embryopathy' — the first published phenotype Hersh et al. 1985. Nine years later, Pearson and colleagues at the University of Arizona delineated the full phenotype across 18 infants toluene-exposed in utero through chronic maternal solvent abuse — Pearson, Hoyme, Seaver & Rimsza 1994, Pediatrics 93(2) born to mothers who had chronically abused pure toluene during pregnancy. Of the 18: 39% premature birth in toluene-exposed infants — Pearson 1994, n=18 were premature, 9% died perinatally, 54% were small for gestational age, 33% had prenatal microcephaly that became 67% postnatally, 80% had developmental delay, 83% had craniofacial features overlapping fetal alcohol syndromeA pattern of growth restriction, characteristic facial features, and central-nervous-system impairment caused by chronic prenatal alcohol exposure; the most well-characterised teratogenic phenotype in modern medicine, and 89% had additional minor anomalies Pearson et al. 1994. The authors proposed that toluene and ethanol disrupt fetal development through a shared craniofacial teratogenesis mechanism.

These case series are uncomfortable evidence. The mothers were chronic solvent abusers — inhaling thousands of parts per million of pure toluene daily, far above any conceivable occupational exposure. The studies cannot tell you what happens at workplace concentrations, let alone at consumer-product concentrations. The broader 1991 Donald-Hooper-Hopenhayn-Rich review of the animal and human reproductive literature in EHPEnvironmental Health Perspectives — the peer-reviewed monthly journal published by the US National Institute of Environmental Health Sciences concluded the same thing: clear teratogenic effects in animal models at high doses, plausible mechanism, and human evidence dominated by solvent-abuse case series with confounders. The biology that produced toluene embryopathy in 18 newborns at heroic exposure is the same biology operating at lower doses. We just don't know where the threshold is, or whether one exists.

The nail-salon workforce in the United States is overwhelmingly female and disproportionately Vietnamese-American — community surveys and industry reports place the proportion in California well above 70%. The job involves sustained low-level inhalation of a multi-solvent cocktail: toluene from polish, ethyl acetate and butyl acetate from polish remover, methyl methacrylate and ethyl methacrylate from acrylic powder, formaldehyde from disinfectant. The exposure question is real. The cancer-outcome answer is partly reassuring.

California's cosmetology-licensing database — 325,228 women California cosmetology and manicurist licensees followed 1988-2005, linked to California Cancer Registry; 9,044 incident cancers — Quach et al. 2010, Am J Epidemiol 172(6) licensed between 1988 and 2005 — was linked to the state cancer registry to track who got which cancer, identifying 9,044 incident cancers across the cohort. The headline finding was that cosmetologists overall had a lower all-sites cancer rate than the general female population: rate ratio 0.84, 95% CI 0.82-0.86 for cosmetologists; 0.87 (0.84-0.90) for manicurists — Quach 2010 than the general female California population: rate ratio 0.84 (95% CI 0.82-0.86) for cosmetologists, 0.87 (0.84-0.90) for manicurists Quach et al. 2010. The site-specific picture was more nuanced: thyroid cancer was elevated across all licensees (PIRProportional Incidence Ratio — the ratio of observed cancer cases at a specific site to the expected number, given the cohort's overall cancer count 1.13, 95% CI 1.04-1.23), and lung cancer was elevated specifically among manicurists (PIR 1.21, 95% CI 1.07-1.36). The lung-cancer signal in manicurists is the closest the cohort came to a chemical-exposure fingerprint.

NIOSHNational Institute for Occupational Safety and Health walked into four nail salons with personal air samplers in 2014-2015 and reported (Health Hazard Evaluation 2014-0139-3338) that personal toluene concentrations were below all applicable occupational exposure limits at every salon — but personal formaldehyde (from disinfection) exceeded the NIOSH REL at some, and not a single salon met federal ventilation guidelines or had local exhaust at the manicure station. The toluene number was reassuring. The ventilation finding wasn't. A 2008 community-based survey of 71 Vietnamese-American nail technicians in Boston found work-related musculoskeletal pain, skin problems, respiratory irritation, and headaches — and a strong protective association for skin problems with glove use Roelofs et al. 2008. The salon problem isn't acute toluene poisoning. It's chronic low-level multi-chemical exposure in a poorly ventilated room that the worker stands in for forty hours a week.

The regulatory picture has two distinct halves: the part that protects workers (occupational exposure limits) and the part that protects consumers (cosmetics, household-product, environmental). Both have moved unevenly across jurisdictions. The European Union has done substantially more on consumer cosmetics. The United States has done more on environmental air quality but less on cosmetic regulation. California is the only U.S. state to act independently on toluene in nail products.

The U.S. occupational picture is the strangest part of this regulatory map. OSHAOccupational Safety and Health Administration's 200 ppm permissible exposure limit was set in 1971, copied from the 1968 ACGIH list, and has not been updated in fifty-five years. ACGIH itself moved its limit to 20 ppm in the years since. NIOSH recommends 100 ppm. ATSDR recommends 1 ppm for chronic exposure. Three federal toxicology bodies sit between a factor of ten and a factor of two hundred below the federal regulator. OSHA has the legal authority to update its limit. Several attempts have failed under industry challenge. The 200 ppm number remains in the Code of Federal Regulations.

On the consumer side, the EUEuropean Union restricted toluene to 25% in nail products under Cosmetics Regulation 1223/2009 (Annex III), and capped its use in adhesives and spray paints intended for the general public at 0.1% under the ECHAEuropean Chemicals Agency — the EU agency that administers REACH and CLP, headquartered in Helsinki-administered REACHRegistration, Evaluation, Authorisation and Restriction of Chemicals — the EU's 2006 framework regulation governing the manufacture, import, and use of chemical substances framework (Annex XVII entry 48) — recognising that a child or adult unwrapping contact cement at home is in a different exposure context to a worker with ventilation. EU REACH restriction in consumer adhesives + spray paints 2007 The UK retained both rules under the Product Safety and Metrology etc. (EU Exit) Regulations 2019 (SI 2019/696). California's Department of Toxic Substances Control listed nail products containing toluene as a Priority Product under the Safer Consumer Products framework, effective 2023, triggering a manufacturer obligation to evaluate alternatives or reformulate (Cal DTSC SCP, Cal Code Regs Title 22 §69511 et seq.). US-CA DTSC Safer Consumer Products listing 2023 Notably, California's higher-profile Toxic-Free Cosmetics Act AB 2762, which took effect 1 January 2025, does NOT include toluene on its 24-substance prohibition list — that act targets formaldehyde, paraformaldehyde, methylene glycol, mercury, parabens, phthalates, and PFAS, not the BTEX solvents.

For a non-smoker who doesn't work with solvents professionally, the cumulative dose is small and the highest-exposure events are concentrated in a few specific moments — applying nail polish in a closed bathroom, painting a bedroom, refuelling a car, sitting in heavy traffic. Reducing exposure is mostly about reducing the concentration in the air you breathe during those events, not avoiding the chemical entirely (which isn't possible at a societal level).

The eso-friendly approach on toluene isn't avoidance. It's contextual. Read your nail polish label. Ventilate when you paint. Don't store solvents indoors. The chemicals in your home that we'd worry more about — the ones with consumer-relevant endocrine disruption at chronic low doses — are phthalates, formaldehyde-releasing preservatives, and the cocktail of fragrance ingredients that hide behind the word 'parfum'. Toluene is a real exposure with real evidence behind it, and it earns a place on the list. It also earns its hedges.

Toluene is the chemical-safety story that doesn't fit cleanly into the endocrine-disruption thesis the rest of this library is built around. It isn't a hormone mimic. It isn't a carcinogen. It's a solvent — a workhorse aromatic hydrocarbon used in millions of tonnes a year — that does measurable, dose-dependent damage to nerves and to fetuses at chronic high exposure, and unmeasurable amounts of damage to most consumers at most exposures. The OSHA limit is the one piece of this story that should bother you regardless of where you stand on the consumer-exposure question. A federal occupational standard set in 1971, a factor of ten above what modern toxicology recommends, never updated. Read the back of the bottle. Open the window. The next time you fill the car, stand a step back from the pump.